Tabula Rasa HealthCare, Inc. - TRHC STOCK NEWS

Tabula Rasa HealthCare (TRHC) will host a conference call on February 25, 2022, at 8:30 a.m. EDT, to discuss its fourth quarter and full year 2021 operating results. The financial results will be released on February 24, 2022, after market close. Key executives will lead the call, providing insights into the company's performance. Interested parties can access the call through TRHC's website or by dialing in with a specified passcode. The company, which offers medication safety solutions, aims to optimize patient care and reduce adverse drug events.

On February 9, 2022, Tabula Rasa HealthCare (TRHC) announced a non-binding Letter of Intent to sell its DoseMeRx solution. This decision aligns with the company's strategy to focus on core assets and enhance shareholder value. According to CEO Calvin H. Knowlton, the move is intended to sharpen TRHC's focus on its primary mission while unlocking value in non-core assets. DosMeRx provides advanced precision dosing tools to improve patient outcomes in medication management.

Tabula Rasa HealthCare (TRHC) has announced a five-year contract renewal with Evernorth, enhancing the use of its Medication Therapy Management (MTM) programs. This agreement builds on a decade-long partnership, with TRHC providing innovative solutions that have achieved over $700 million in cost savings through 9 million medication-related interventions. TRHC will continue to deliver MTM services to millions of Medicare, Medicaid, and commercial members, utilizing its extensive pharmacy network to improve member engagement and satisfaction.

Tabula Rasa HealthCare, Inc. (TRHC) announced results from two peer-reviewed studies focusing on opioid-drug interactions using MedWise® Science. The first study published in the Journal of Personalized Medicine revealed that patients on opioids who also take interacting medications face increased medical expenses and risks of adverse events. The second study in the Journal of Palliative Medicine highlighted how genetic data can enhance medication safety for opioid users, with 85% of clinicians reporting improved patient care through MedWise's decision support tools.

Tabula Rasa HealthCare (TRHC) hosted its 2021 CareVention HealthCare Advisory Summit in Orlando, focusing on growth opportunities in the Program of All-Inclusive Care for the Elderly (PACE). Key discussions included the PACE Plus Act aimed at enhancing site approvals and affordability for Medicare beneficiaries. TRHC emphasized the increasing role of technology in home-based care, with industry leaders advocating for innovative services. The summit, now in its third year, included both in-person and virtual participation, facilitating valuable networking.

Tabula Rasa HealthCare (TRHC) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. Co-President Brian W. Adams and Senior VP Frank Sparacino will engage in a fireside discussion. This session can be viewed on TRHC's Investor site and the conference site. Presentations can be accessed until December 2, 2021.

Tabula Rasa HealthCare, Inc. (TRHC) has renewed a five-year contract with Rocky Mountain PACE, enhancing medication management services for over 800 participants in Colorado Springs. The partnership utilizes TRHC's CareKinesis, which offers personalized medication management and 24/7 clinical pharmacist support, improving medication safety and adherence. Rocky Mountain PACE has successfully implemented these services since 2018, contributing to better participant outcomes. The ongoing collaboration highlights TRHC's strong position in medication safety solutions aimed at reducing adverse drug events.

Tabula Rasa HealthCare (TRHC) announced significant organizational changes aimed at strengthening its corporate structure and promoting strategic growth, particularly for its MedWise solutions. Effective immediately, Brian W. Adams is appointed Co-President while retaining his CFO role. This move is designed to unify critical functions within the company and allow CEO Calvin H. Knowlton to focus on broader strategic goals. Adams brings extensive experience in strategic acquisitions and financial optimization, while Orsula V. Knowlton will also enhance diversity efforts alongside her marketing role.

Tabula Rasa HealthCare, Inc. (TRHC) reported a revenue increase of 23% to $86.6 million for Q3 2021, compared to $70.5 million in Q3 2020. This growth was driven by a 29% rise in product revenue and a 15% increase in solutions revenue. The acquisition of Personica contributed 6% to total revenue growth. Despite this, the company reported a GAAP net loss of $17.1 million, an improvement from $21.6 million a year earlier. TRHC expects Q4 2021 revenue of $84-86 million and full-year revenue between $329.6-331.6 million, reflecting organic growth of 7%.